Consolidated Condensed Statements of Cash Flow - USD ($) $ in Millions	8 Months Ended	9 Months Ended
	Sep. 10, 2016	Sep. 30, 2017
OPERATING ACTIVITIES
Net earnings	$ 89.9	$ 60.1
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	30.0	28.0
Deferred income taxes	(0.6)	(13.2)
Stock-based compensation expense	15.3	19.1
Excess tax benefits from stock-based compensation	(0.4)	0.0
Pension contribution	(0.4)	(11.1)
Pension and SERP expense	7.3	11.2
Restructuring and impairment costs	17.6	73.9
Cash payments related to restructuring costs	(11.2)	(58.9)
(Gain)/loss on sale of a business and other assets	0.0	(7.0)
Other	(4.8)	(12.1)
Changes in operating assets and liabilities:
Accounts receivable	(12.7)	(24.3)
Inventories	8.3	(15.1)
Other operating assets	10.1	1.9
Accounts payable	(34.7)	(10.0)
Other operating liabilities	29.5	7.0
Net cash provided by operating activities	143.2	49.5
INVESTING ACTIVITIES
Additions to property, plant and equipment	(34.4)	(28.7)
Proceeds from sale of a business and other assets	0.0	38.0
Investment in joint venture	(0.5)	0.0
Other	10.4	(4.1)
Net cash provided by (used in) investing activities	(24.5)	5.2
FINANCING ACTIVITIES
Net borrowings under revolving credit agreements and other short-term notes	1.2	0.3
Borrowings of long-term debt	250.0	0.0
Payments on long-term debt	(5.7)	(26.2)
Payments of debt issuance costs	(3.4)	(0.1)
Cash dividends paid	(17.7)	(17.4)
Purchases of common stock for treasury	(11.4)	(51.5)
Purchases of shares under employee stock plans	(4.7)	(5.2)
Proceeds from the exercise of stock options	5.6	11.9
Excess tax benefits from stock-based compensation	0.4	0.0
Contributions from noncontrolling interests	2.2	0.8
Net cash provided by (used in) financing activities	216.5	(87.4)
Effect of foreign exchange rate changes	1.6	5.6
Increase (decrease) in cash and cash equivalents	336.8	(27.1)
Cash and cash equivalents at beginning of the year	194.1	369.8
Cash and cash equivalents at end of the period	$ 530.9	$ 342.7